Home > Press > The next small thing: Pioneering nanotech centre is launched
The next small thing: Pioneering nanotech centre is launched
Posted on October 30, 2006
A unique multidisciplinary UK research facility that will be at the forefront of delivering applied nanotechnology solutions will be opened on Tuesday 7 November 2006 at UCL (University College London).
The London Centre for Nanotechnology (LCN), which is a joint venture between UCL and Imperial College London, harnesses the world-class expertise of the two institutions across the physical, engineering and biomedical sciences to meet the needs of society and industry - and in particular improve patient care.
The £25 million centre occupies a purpose-built eight-storey facility in Gordon Street, Bloomsbury, as well as extensive facilities within different departments at Imperial's South Kensington campus. Designed by the architects Feilden Clegg Bradley, the Bloomsbury site embraces 21st-century equipment crucial to the application of nanotechnology. The fabric of the building had to be purpose-designed for ultra-low vibration which will allow experiments with molecules - which are so sensitive that in a normal environment, the vibrations of a person walking at the other side of the building could destroy the experiment - to be conducted.
To mark the opening of the building, journalists are invited to a symposium where the future of nanotechnology and its application will be discussed by:
The symposium will be followed by a reception in the UCL Jeremy Bentham Room where attendees will get the chance to meet many of the 200 LCN researchers and discuss their work.
Professor Gabriel Aeppli, Director of the LCN, says: "The LCN is truly interdisciplinary in its nature. Researchers from eight different academic departments are working together on projects which require skill combinations that no individual scientist or even traditional academic department can contribute. Physicists are literally sitting next to medical doctors, chemists and engineers, paving the way for unique collaborations.
"LCN researchers have shown how nanotechnology can be used for cancer diagnostics, which they are already commercialising via a start-up company. In a decade we expect to see a new, nanotechnology-enabled generation of personalised drugs capable of targeting specific cells such as tumours, as well as new medical diagnostics. This will change the face of healthcare."
Journalists who wish to register attendance for the event or find out more should contact:
Judith H Moore, UCL Media Relations, Tel: +44 (0)20 7679 7678, Mobile: +44 (0)77333 075 96, Email: judith.moore@ucl.ac.uk.
Notes for Editors
Further information about the London Centre for Nanotechnology can be found at: www.lcn.ucl.ac.uk/
Event format:
14.15-14.45 Guests arrive at the UCL Bloomsbury theatre
15.00 -16.10 Symposium - 'Nanotechnology, Innovation and Interdisciplinarity'
16.15-18.00 Reception in the UCL Jeremy Bentham Room
About London Centre for Nanotechnology:
The London Centre for Nanotechnology is a joint enterprise between University College London and Imperial College London. In bringing together world-class infrastructure and leading nanotechnology research activities, the centre aims to attain the critical mass to compete with the best facilities abroad. Furthermore by acting as a bridge between the biomedical, physical, chemical and engineering sciences the centre will cross the 'chip-to-cell interface' - an essential step if the UK is to remain internationally competitive in biotechnology.
The new LCN building is an eight storey building at 17-19 Gordon Street on the UCL campus. The main elevation to Gordon Street is sympathetic to the proportions of the surrounding conservation area and is unique not only in its technical specifications, but has been designed specifically to enhance the interdisciplinary research work carried out within. The elevation is split into three distinct zones, reflecting the different building uses within, and also aligning with the traditional base, middle and top/attic stories of the classically composed elevations adjacent.
The laboratory spaces, including a 200 square metre Clean Room, have exceptionally rigorous specifications with tightly controlled and stable environment conditions. Much of the building houses highly sensitive instruments for the preparation and investigation of nanoscale structures and materials.
For more information, please click here
About Imperial College London:
Consistently rated in the top three UK university institutions, Imperial College London is a world leading science-based university whose reputation for excellence in teaching and research attracts students (11,000) and staff (6,000) of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and management and delivers practical solutions that enhance the quality of life and the environment - underpinned by a dynamic enterprise culture.
For more information, please click here
About UCL:
Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence.
UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone); and members of the band Coldplay.
For more information, please click here
Contact:
Judith H Moore
UCL Media Relations
Tel: +44 (0)20 7679 7678
Mobile: +44 (0)77333 075 96
judith.moore@ucl.ac.uk.
Copyright © UCL
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||